Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 5]
Pharmac Seeking Feedback On Funding Trikafta
Sunday, 4 December 2022, 7:02 pm | PHARMAC
4 December 2022 Te Pātaka Whaioranga – Pharmac has reached a provisional agreement with medicine supplier Vertex to fund Trikafta. “Following our budget increase in May 2022 and commercial negotiations with the supplier, Vertex, I am thrilled ... More >>
Pharmac Welcomes Myeloma NZ As First Patient Advocacy Group To Present To PTAC
Monday, 21 November 2022, 9:50 am | PHARMAC
Myeloma New Zealand presented directly to Pharmac’s Pharmacology and Therapeutics Advisory Committee (PTAC) on Thursday, making them the first patient advocacy group to do so. As Pharmac continues to work to improve its processes around consumer involvement, ... More >>
Pharmac Widens Access To Pneumococcal Vaccine
Monday, 7 November 2022, 1:01 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac has announced today that all young tamariki will receive access to the PCV13 pneumococcal vaccine (brand name Prevenar 13) as part of the childhood immunisation programme, instead of the currently funded PCV10 vaccine ... More >>
Pharmac Seeks Feedback On The Funding Of Paediatric Cancer Medicines
Wednesday, 2 November 2022, 5:18 am | PHARMAC
Te Pātaka Whaioranga Pharmac is seeking feedback on rule 8.1b of the Pharmaceutical Schedule – a unique exception that means any medicine currently used to treat cancer in a paediatric setting is automatically funded without a Pharmac assessment. “We ... More >>
Pharmac Considers Funding Meningococcal B Vaccine To Be Part Of Childhood Immunisations
Tuesday, 25 October 2022, 4:00 pm | PHARMAC
Pharmac today has announced a consultation on widening access to the meningococcal B vaccine (branded as Bexsero) which would give thousands of young people and infants protection against meningococcal B disease. The proposal would allow for its inclusion ... More >>
Pharmac Considering More Options For People With Inflammatory Bowel Disease
Tuesday, 11 October 2022, 5:47 pm | PHARMAC
Te Pātaka Whaioranga - Pharmac has initiated consultation today to fund ustekinumab (branded as Stelara) for people with inflammatory bowel disease (IBD) and to widen access to infliximab (branded as Remicade) for IBD-associated arthritis. “Following ... More >>
Pharmac Seeking Feedback On Nusinersen And Adrenaline Auto-injectors Funding
Wednesday, 28 September 2022, 6:21 am | PHARMAC
Te Pātaka Whaioranga - Pharmac has initiated two consultations today, seeking feedback on the funding of two different medicines that we've heard are very important to many New Zealanders. One is for funding nusinersen (branded as Spinraza) for people ... More >>
Pharmac Considering Multiple New Treatments
Monday, 19 September 2022, 1:48 pm | PHARMAC
Te Pātaka Whaioranga - Pharmac has initiated consultation today on a provisional bundle deal with pharmaceutical manufacturer Takeda to fund vedolizumab for people with inflammatory bowel disease and brentuximab vedotin for people with relapsed ... More >>
Progesterone To Be Fully Funded For All Who Need It
Thursday, 15 September 2022, 10:05 am | PHARMAC
Pharmac has today confirmed that it is removing all funding restrictions from progesterone , with tens of thousands of New Zealanders expected to benefit from access to the hormone replacement therapy. “Up until now progesterone has been funded only for ... More >>
Pharmac Announces Medicines Bundle To Provide More Treatment Options For New Zealanders
Wednesday, 14 September 2022, 12:57 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac is considering funding two medicines as part of a new bundle agreement that would offer new treatment options for people experiencing schizophrenia and for people with one type of blood cancer. In the consultation issued ... More >>
Pharmac Simplifies Criteria For COVID-19 Antiviral Treatments
Tuesday, 13 September 2022, 5:33 am | PHARMAC
12 September Te Pātaka Whaioranga - Pharmac has confirmed today that it is simplifying the access criteria for the three antiviral treatments it funds for treating early COVID-19. From Wednesday 14 September 2022, the number of people who can access these ... More >>
Pharmac Considering Multiple New Treatments
Wednesday, 31 August 2022, 12:38 pm | PHARMAC
Te Pātaka Whaioranga - Pharmac is considering funding five different medicines which would give thousands of New Zealanders more treatment options for a range of health of conditions. In the consultation issued today, Pharmac is seeking feedback ... More >>
PHARMAC: Access Criteria For New COVID-19 Treatment Announced
Thursday, 25 August 2022, 6:12 am | PHARMAC
Pharmac has today confirmed the access criteria for the first preventative medicine for COVID-19, tixagevimab and cilgavimab (branded as Evusheld), for severely immunocompromised New Zealanders. Read the access criteria “Being vaccinated and boosted is the best ... More >>
Pharmac Shares Update On Its Assessment Of Trikafta
Monday, 15 August 2022, 1:08 pm | PHARMAC
Pharmac has today published the latest record of advice from its Pharmacology and Therapeutics Advisory Committee (PTAC) and, for the first time, has published a summary of how Pharmac has assessed Trikafta. “Trikafta is a medicine we would like to ... More >>
Aotearoa Less Affected By Medicine Supply Issues Than Other Countries
Friday, 22 July 2022, 6:42 am | PHARMAC
22 July 2022 Te Pātaka Whaioranga - Pharmac’s work behind the scenes and unique arrangements with suppliers means Aotearoa has been less affected by ongoing supply disruptions than other countries. Currently there are 47 medicine supply issues notified ... More >>
Pharmac Widens Access For COVID 19 Antiviral Treatments
Thursday, 14 July 2022, 12:51 pm | PHARMAC
Te Pātaka Whaioranga - Pharmac has confirmed today that it is further widening access to the three antiviral treatments it funds for treating early COVID-19 to more than 400,000 more New Zealanders if they get the virus. Pharmac funds nirmatrelvir ... More >>
Pharmac Considering Funding New Medicines For Lung Cancer
Wednesday, 6 July 2022, 12:33 pm | PHARMAC
Pharmac, the medicine funding agency for Aotearoa is seeking proposals from pharmaceutical suppliers for medicines that could treat New Zealanders with lung cancer. “Lung cancer is one of the most commonly diagnosed cancers in Aotearoa and it is the leading ... More >>
Accuretic Supply Issue, Almost 36,000 New Zealanders Taking The Blood Pressure Medicine Will Need To Change Treatments
Thursday, 30 June 2022, 5:46 am | PHARMAC
Pharmac has updated health care professionals that supply of quinapril with hydrochlorothiazide (branded as Accuretic), from supplier Pfizer, will be disrupted due to the detection of a contaminant called nitrosamine. This is a global issue, with voluntary recalls ... More >>
Pharmac Widens Flu Vaccine Access To Increase Uptake
Monday, 27 June 2022, 7:29 am | PHARMAC
Pharmac today announced that it is permanently widening access to the annual funded flu vaccine to people with specific mental health conditions and or addiction issues, as well for children aged 3 to 12 years for the rest of the 2022 flu season. The ... More >>
Pharmac Announces First Round Of Medicine Funding Decisions Following $191m Pharmaceutical Budget Increase
Wednesday, 15 June 2022, 10:38 am | PHARMAC
Pharmac today announces the first round of changes to medicines funding following its $191 million pharmaceutical budget increase over the next two years. The first changes include funding blood and breast cancer medicines, widening funded access ... More >>
